webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More
  1. Home
  2. Products
  3. ADC Cytotoxin with Linker
  4. DBCO-PEG4-GGFG-DMEA-PNU159682

DBCO-PEG4-GGFG-DMEA-PNU159682

  CAS No.:   Cat No.: BADC-01421 4.5  

DBCO-PEG4-GGFG-DMEA-PNU159682 is a click-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs).

DBCO-PEG4-GGFG-DMEA-PNU159682

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin with Linker
Molecular Formula
C82H97N9O25
Molecular Weight
1608.72

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
N-[20-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-17,20-dioxo-4,7,10,13-tetraoxa-16-azaicosan-1-oyl]glycylglycyl-L-phenylalanyl-N-methyl-N-{2-[methyl({2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-4-{[(1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5][1,3]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy}-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-tetracenyl]ethoxy}carbonyl)amino]ethyl}glycinamide; Glycinamide, N-[20-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-1,17,20-trioxo-4,7,10,13-tetraoxa-16-azaeicos-1-yl]glycylglycyl-L-phenylalanyl-N-[2-[[[2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-4-[[(1S,3R,4aS,9S,9aR,10aS)-octahydro-9-methoxy-1-methyl-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy]-6,11-dioxo-2-naphthacenyl]-2-oxoethoxy]carbonyl]methylamino]ethyl]-N-methyl-
InChI
InChI=1S/C82H97N9O25/c1-49-77-58(90-30-33-112-80(107-5)79(90)116-77)41-68(114-49)115-60-43-82(105,42-55-70(60)76(102)72-71(74(55)100)73(99)54-19-13-21-59(106-4)69(54)75(72)101)61(92)48-113-81(104)89(3)29-28-88(2)67(98)46-86-78(103)56(40-50-14-7-6-8-15-50)87-65(96)45-85-64(95)44-84-63(94)26-31-108-34-36-110-38-39-111-37-35-109-32-27-83-62(93)24-25-66(97)91-47-53-18-10-9-16-51(53)22-23-52-17-11-12-20-57(52)91/h6-21,49,56,58,60,68,77,79-80,100,102,105H,24-48H2,1-5H3,(H,83,93)(H,84,94)(H,85,95)(H,86,103)(H,87,96)/t49-,56-,58-,60-,68-,77+,79+,80-,82-/m0/s1
InChIKey
VTRDFAIGBFUTST-LNNNDNRNSA-N
Density
1.5±0.1 g/cm3

DBCO-PEG4-GGFG-DMEA-PNU159682, a versatile compound with multifaceted applications in research and therapeutic advancement, is a cornerstone in various scientific fields.

Click Chemistry: Widely embraced in click chemistry, DBCO-PEG4-GGFG-DMEA-PNU159682 plays a pivotal role in bioconjugation endeavors. The reactive DBCO moiety swiftly interacts with azide groups, facilitating the precise labeling and modification of biomolecules. This click reaction, characterized by remarkable efficiency, operates seamlessly under gentle conditions, making it a prime choice for live-cell imaging and protein-tagging investigations.

Drug Delivery: Boasting a PEG4 spacer, DBCO-PEG4-GGFG-DMEA-PNU159682 enhances solubility and stability, a boon for drug delivery applications. By conjugating it with therapeutic agents, researchers optimize the pharmacokinetics and biodistribution of drugs, enabling targeted delivery of potent anticancer medications like PNU159682. This targeted approach not only diminishes adverse effects but also enhances therapeutic outcomes significantly.

Protease-Responsive Prodrugs: The GGFG linker, a discernible peptide sequence susceptible to specific proteases, endows DBCO-PEG4-GGFG-DMEA-PNU159682 with invaluable utility in prodrug development. Following cleavage by target proteases in the tumor microenvironment, the potent drug PNU159682 is liberated. This strategic design allows for precise activation of drugs at the intended site, mitigating systemic toxicity and amplifying therapeutic efficacy.

Bioorthogonal Labeling: Positioned as a key player in bioorthogonal labeling, DBCO-PEG4-GGFG-DMEA-PNU159682 facilitates the labeling of biomolecules in intricate biological systems. The DBCO group selectively engages with azide-functionalized probes without disrupting natural cellular processes. This precision enables meticulous tracking and visualization of biomolecules in live-cell assays and in vivo studies, facilitating cutting-edge research in cell biology and molecular imaging.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Calculate
The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Calculate

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload ADC Linker–Payload Conjugation ADC Linker Development Chemical Payload Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Linkers - A Crucial Factor in Antibody–Drug Conjugates Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC Cytotoxin with Linker

ADC Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

ADC Linker

Precise Conjugation For Success

Antibody-Drug Conjugates (ADCs)

Antibody-Drug Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: MAL-di-EG-Val-Cit-PAB-MMAF | Pomalidomide-PEG3-CO2H | Thalidomide-NH-PEG7 | OSu-Glu-vc-PAB-MMAE | DM1-SMe | DBCO-PEG4-MMAF | MC-Sq-Cit-PAB-Dolastatin10 | DOXO-EMCH | DBCO-PEG4-DMEA-PNU159682 | Acetylene-linker-Val-Cit-PABC-MMAE | DBCO-PEG4-GGFG-DMEA-PNU159682
Send Inquiry
Verification code
Inquiry Basket
loading Loading ......
Delete selectedGo to checkout